The Deal Register
Database › Equity financing › Innocan Pharma Corporation Anticipates Listing on the NYSE American…

Equity financing

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Lane
Equity financing
Announced
02 Jan 2026
Province
Alberta
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates to list on NYSE American on or around January 7, 2026, subject to approval of its listing application and continued compliance with exchange rules." subject to authorization of the application and continued compliance with the exchange rules.
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe